InvestorsHub Logo

orangecat

09/19/18 7:16 PM

#1909 RE: micham2012 #1908

My guess is traders taking profit and moving it to the next biotech with a likely positive binary event.

weeblewobble09

09/20/18 8:55 AM

#1912 RE: micham2012 #1908

Vikings market cap is ten times that of CNAT. Shows the potential of cnat.

Inoviorulez

09/20/18 5:57 PM

#1915 RE: micham2012 #1908

Because CNAT has already shown to reduce fibrosis. In the POLT study from F3 through F5 fibrosis population it achieved a 95% response rate. Even though the title read as a fail, in essence the trial was a success. If you were to also take out the 3 placebo patients with F6 level fibrosis at 100% the trial would have met on the primary endpoint.